Table 5 Baseline characteristics prior to hospitalization for 49 patients (with CR-AB and/or CR-PA) and 438 controls (without CR-AB and CR-PA)
Baseline characteristics | CR-AB and/or CR-PA (n = 49) | No CR-AB and CR-PA (n = 438) | p-value |
|---|---|---|---|
Mean age ± SD (years) | 66.7 ± 18 | 61.1 ± 17.8 | 0.04 |
Male gender | 18 (36.7%) | 203 (46.4%) | 0.20 |
Previous hospitalization | 32 (65.3%) | 179 (40.9%) | 0.001 |
Transfer status | |||
From other hospital | 13 (26.5%) | 43 (9.8%) | 0.001 |
From a long-term care facility | 4 (8.2%) | 2 (0.5%) | < 0.001 |
Underlying diseases | |||
Any underlying disease | 48 (98.0%) | 372 (84.9%) | 0.01 |
Hypertension | 33 (67.4%) | 257 (58.7%) | 0.24 |
Diabetes mellitus | 20 (40.8%) | 164 (37.4%) | 0.64 |
Cardiovascular disease | 16 (32.7%) | 117 (26.7%) | 0.38 |
Cerebrovascular disease | 23 (46.9%) | 74 (16.9%) | < 0.001 |
Chronic liver disease | 9 (18.4%) | 79 (18.0%) | 0.95 |
Chronic renal disease | 8 (16.3%) | 56 (12.8%) | 0.49 |
Chronic lung disease | 7 (14.3%) | 56 (12.8%) | 0.77 |
Malignancy | 7 (14.3%) | 80 (18.3%) | 0.49 |
Solid malignancy | 7 (14.3%) | 68 (15.5%) | 0.82 |
Hematologic malignancy | 0 | 12 (2.7%) | 0.24 |
Hematologic diseases | 6 (12.2%) | 41 (9.4%) | 0.52 |
Prior organ transplantation | 1 (2.0%) | 6 (1.4%) | 0.71 |
Receipt of any immunosuppressive agent | 6 (12.2%) | - 53 (12.1%) | 0.98 |
HIV infection | 1 (2.0%) | 15 (3.4%) | 0.61 |
Previous antibiotic exposure within 90 days after hospitalization | |||
Any antibiotic | 26 (53.1%) | 122 (27.9%) | < 0.001 |
Penicillins | 1 (2.0%) | 18 (4.1%) | 0.48 |
Cephalosporins | 10 (20.4%) | 50 (11.4%) | 0.07 |
Carbapenems | 9 (18.4%) | 24 (5.5%) | 0.001 |
Beta-lactam/beta-lactamase inhibitors | 7 (14.3%) | 20 (4.6%) | 0.005 |
Fluoroquinolones | 8 (16.3%) | 38 (8.7%) | 0.08 |
Macrolides | 4 (8.2%) | 15 (3.4%) | 0.10 |
Others | 8 (16.3%) | 34 (7.8%) | 0.04 |
Previous use of indwelling catheters | |||
Urinary catheter | 19 (38.8%) | 54 (12.3%) | < 0.001 |
Nasogastric tube | 16 (32.7%) | 29 (6.6%) | < 0.001 |